Benefits of pulsatile machine perfusion (pumping) of standard criteria donor (SCD) kidneys are unclear. Our center is located 4½ hours from our Organ Procurement Organization. We evaluated outcomes of pumping SCD kidneys under such circumstances by conducting a retrospective examination of all SCD kidneys transplanted between January 2007 and March 2012, comparing kidneys pumped (28 [group 1]) versus standard cold storage (77 [group 2]). Group 1 had fewer delayed graft function (DGF, 3.57% vs. 23.38%, p = 0.02) and slow graft function (SGF, 7.14% vs. 24.68%; p = 0.047) and faster serum creatinine recovery curve (p < 0.001) than group 2. Having a kidney pumped decreases the incidence (odds ratio [OR], 0.059) of DGF, SGF, or primary nonfunction. Group 1 were quicker to reach an estimated glomerular filtration rate (eGFR) >30 ml/min (OR, 4.186; confidence interval [CI], [2.448-7.157]) or an eGFR >60 ml/min (OR, 2.669; CI [1.255-5.679]). Pumping the SCD kidneys in a geographically remote transplant center tended to be better than those preserved in cold storage. However, except recovery curve of serum creatinine during the first postoperative month, other parameters failed to reach statistical significance in the post hoc examination of the contemporary groups. Prospective paired kidney study is required to scrutinize this finding. ASAIO Journal 2014; 60:76-80.
Pulsatile machine perfusion (PMP) or pulsatile pumping of the kidneys to be transplanted had been reported as early as in the 1970s, 1,2 and initial results were divisive. [1] [2] [3] [4] Even some complications were reported. 5 With the improvements of the machine itself, the techniques of PMP, the solution, and some additives used, recent data are more favorable for PMP, especially with regard to marginal donor kidneys (expanded criteria donor [ECD] or donation after cardiac death [DCD] ). 6, 7 The value of pumping marginal donor kidneys has been established as "standard of practice" in many Organ Procurement Organizations (OPO) and transplant centers to decrease the incidence of delayed graft function (DGF, defined as the necessity of dialysis within the first 7 days after transplant) 8 ; however, the benefits of pulsatile machine perfusion for standard criteria donor (SCD) kidneys remain contentious. 3, 4, 9, 10 Historically, the rate of DGF at our institution was around 30%. A possible contributing factor identified was that the transplant center is located 4½ hours from our OPO. This geographical disadvantage prolongs ischemic time, which potentially leads to an increase in DGF rate and medical cost. Therefore, we began using the portable PMP pump (LifePort; Organ Recovery System, Itasca, IL) in late 2009. According to our OPO policy, all marginal donor kidneys (ECD or, as suggested by the editorial office, DCD) are to be mechanically pumped. However, because of logistic reasons, SCD kidneys were evaluated on a case-by-case basis and were only pumped if requested by the transplant surgeon. Furthermore, since the initial implementation of using the pump, there was a clinically perceived decrease in the occurrence of DGF among our kidney transplant recipients. Thus, we wanted to evaluate the benefits of routinely pumping SCD kidneys under such specific geographic circumstances.
Patients and Methods
A retrospective single cohort cross-sectional study was approved by our institutional review board (1997139) to examine the effect of pumping SCD kidneys by examining all the SCD kidneys transplanted from January 2007 to March 2012. Because the pulsatile pumping became available in August 2009, SCD kidneys were pumped on a case-by-case basis because of logistic issues that did not allow the transplant surgery to proceed as soon as possible, namely the operation room availability, surgeon's working schedule, or other recipients' factors. At the time of requesting that the kidneys be pumped, the surgeon did not use any clinical parameters of the donors to make such decisions but mainly considered the logistics. Retrospective examination of our SCD kidneys transplanted with PMP or the standard static cold storage (CS, ice packing) method was conducted to assess the incidence of DGF as a primary end-point. Secondary end-points were the incidence of slow graft function (SGF; defined as no dialysis needed after transplant but serum creatinine >3 mg/dl on postoperative day 5), 11 incidence of oliguria (defined as <0.5 ml/kg/h in children and <400 ml/d in adults), incidence of primary nonfunction (PNF), the recovery curve of serum creatinine level and estimated glomerular filtration rate (eGFR, ml/min, calculated by Modification of Diet in Renal Disease [MDRD] formula), 12 incidence of acute rejection, the length of hospital stay, the inpatient cost (which was derived from the hospital billing office as the amount that the total direct cost the hospital incurred performing the patient's care from that transplant admission encounter; this does not include the kidney acquisition charge, professional fees, or outpatient costs after discharge from the transplant admission encounter), allograft, and patient survival.
The pulsatile perfusion was requested by the surgeon to our OPO administrator-on-call. After approval was obtained, the perfusionist-on-duty at our OPO would transport the kidneys recovered back to the OPO and install the machine perfusion according to the details of their policy. The PMP kidneys were then transported to our hospital on the pump machine and continuously pumped with the pulsatile perfusion until the time of back-table bench preparation. The kidneys in the control nonpumped group included those SCD kidneys during the study period which were transported to our hospital via the standard static cold storage method. Kidney transplantation procedures and posttransplant care were performed in the standard fashion.
All the 105 SCD kidneys transplanted between January 2007 and March 2012 were reviewed. Of this cohort, recipients of the 28 pulsatile pumped kidneys were then compared with those of the 77 kidneys stored in ice.
Statistical Analysis
Data analysis was conducted by our Institutional Center of Health Services and Outcomes Research. All descriptive statistics were used. Chi-square test/Fisher's exact test (wherever appropriate) was used to analyze categorical variables, and Student's t-test was used to analyze continuous variables between the pumped and the cold storage group. Comparison between serum creatinine recovery curves was performed with repeated measures analysis of variance. Multivariate logistic regression was used to determine which variables predicted patient's probability of DGF, SGF, PNF, or none of the 3. Cox proportional hazards model was used to see the effect of PMP or cold storage, ischemic time, body mass index (BMI), recipient's age, and donor's age on the speed of allograft function recovery at 1, 2, 3, 5, 7, 14, 21, and 28 days after transplant. "Acceptable recovery" was defined as eGFR >30 ml/min, and "excellent recovery" was defined as eGFR >60 ml/min. All comparisons were done at 95% of level of significance. Analyses were done on SAS version 9.2. (SAS Institute Inc., Cary, NC).
Results
Those recipients who received pumped SCD kidneys (group 1) had significantly fewer DGF incidences (1/28, 3.57% vs. 18/77, 23.38%; p = 0.02) than those who received SCD kidneys in cold storage (group 2). Group 1 recipients also had fewer incidences of SGF (2/28, 7.14% vs. 19/77, 24.68%; p = 0.047). The serum creatinine recovery curve is appreciably faster in group 1 during the first posttransplant month ( Figure 1 , p < 0.001).
None of the group 1 recipients had oliguric episodes, and 13 of 77 (16.9%) group 2 recipients experienced oliguria after transplantation. Recipients in group 1 had shorter follow-up and slightly younger donors than those in group 2 ( Table 1) . There was no difference among primary nonfunction rate, incidence of acute rejection, hospital stay, inpatient cost, and graft or patient survivals between these two groups ( Table 1) .
Multivariate logistic regression to predict the effect of various independent variables on the occurrence of DGF, SGF, or PNF versus none of the 3 revealed that having a pumped kidney is less likely (odds ratio [OR], 0.059; confidence interval [CI], [0.013-0.260]) to experience DGF, SGF, or PNF conditions. Higher BMI (OR, 1.159) and longer ischemic time (OR, 1.091) are also more likely to be associated with DGF, SGF, or PNF ( Table 2) . With Cox proportional hazards model, recipients in group 1 were definitely more likely and faster to recover to an acceptable eGFR (>30 ml/min; OR, 4.186; Figure 2A ) and also to an excellent eGFR (>60 ml/min; OR, 2.669; Figure 2B ). Other factors identified to significantly affect the speed of allograft function recovery were listed in Tables 3 and 4. 
Discussion
The advantages of pumping ECD kidneys before transplant are commonly accepted not only for its clinical efficacy but also for its associated cost-effectiveness, 6, 7, 13, 14 whereas the benefits of PMP for SCD kidneys stay controversial. 3, 4, 9, 10, 14, 15 Merion et al. 3 did not see advantages in the incidences of DGF, serum creatinine recovery, and 30-day graft survival in a prospective same donor-controlled trial comparing pumped versus CS kidneys. Contrarily, Alijani et al. 4 showed DGF in 17% of pumped and 63% of CS allografts (p < 0.01) among 29 paired kidneys. Shah et al. 15 reported 5% DGF incidence in pumped versus 35% in CS kidney recipients (p < 0.01) in which one kidney underwent pumping and transplantation at their center, whereas the contralateral kidney underwent CS and transplantation at another center. Kwiatkowski et al. 9 retrospectively demonstrated better 5-year graft survival (68.2% vs. 54.2%, p = 0.02) and fewer cases of interstitial fibrosis/ tubular atrophy (90% vs. 64%, p < 0.05) among pumped kidneys. 16 Moers et al. 10 showed that PMP, in comparison with CS, was associated with a significantly reduced risk of DGF and improved graft survival in 1 year after transplantation in a European international prospective, single-blinded randomized study of 336 consecutive donors. Furthermore, Ciancio et al. 17 in a single-center observational study revealed that PMP with prolonged pump times (≥24 hours) was associated with low DGF/SGF and first acute rejection rates, supporting the use of PMP. However, all of the above-mentioned articles collected data from deceased donors, yet failed to identify whether only SCD kidneys were collected or marginal donor kidneys were also included among their cohorts.
What makes our study unique is that we focused on the short-term outcomes of recipients who received pumped versus CS kidneys solely from SCDs, especially considering our remote geographical location from our OPO; and our total ischemic time averaged 21-23 hours in either group. The results are favorable to the recipients of the pumped group, with significantly less incidence of DGF or SGF and quicker recovery of allograft function (either viewing from serum creatinine recovery or eGFR increment curves). And on multivariate analyses, receiving a pumped kidney strongly stood out as a momentous independent factor for less likelihood of having a DGF, SGF, or PNF event, and earlier recovery to acceptable or excellent eGFR, each with an extreme odds ratio. These statistically significant differences coincided with our operational observations that machine-perfused kidneys usually turned pink with good tone fairly quick after revascularization even after prolonged cold ischemic time, in contrast to dusky and floppy kidneys sometimes seen with kidneys stored in ice. These results support our hypothesis that in our unique geographic location PMP of standard criteria kidneys yields better short-term transplant outcomes.
Hypothermic pumping for the preservation of kidneys might work through several mechanisms, namely, maintaining the patency and reducing the spasm of the vascular bed, providing nutrients and oxygen to support reduced cellular energy Table 1 
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Recipient's age 50. 10 demands, removal of metabolic by-products and toxins, providing access for adding cytoprotective agents, and pump parameters or perfusate biomarkers to provide assays of organ viability assessment. 18, 19 Pump perfusion of deceased donor kidneys facilitates a change from emergency to elective surgery with potential reduced operative costs. 18 Our report has limitations to consider. This study inherits all the possible biases and short-comings of a retrospective single-center observation study. Because we only started using the pulsatile pump machine in the past 2 more years, and more recipients of the CS group were transplanted earlier, the follow-up durations of these two groups were obviously different (16 vs. 32 months). We did a post hoc analysis and found that during the same time period of pumping those 28 SCD kidneys, there were 19 SCD kidneys stored in ice and then transplanted. In comparison with the pump group, there was still a significant statistical difference in the recovery curve of serum creatinine during the first postoperative month (p = 0.02, Figure 1 -1, Supplemental Digital Content 1, http:// links.lww.com/ASAIO/A45). However, the difference in our primary end-point (incidence of DGF) was only at the verge of statistical significance (p = 0.056, Table I -1, Supplemental Digital Content 1, http://links.lww.com/ASAIO/A45), although we were still impressed by the actual number of DGF (3.57% vs. 21.1%). This 21.1% was reasonable because our historical DGF rate was around 30% (counting all deceased donors). There was a trend toward shorter ischemic time in the cold storage group, but the difference was not significant (Table I -1, Supplemental Digital Content 1, http://links.lww. com/ASAIO/A45). It is very likely that the DGF result of marginal significance was because of the small case numbers in the two groups, in which the samples might not be normally distributed. To compare the results of the 19 recipients with those we presented in our Results section, the actual numerical percentages are convincingly similar-the DGF incidence became 23.38% (from 21.1%), and the incidence of SGF became 24.68% (from 26.3%)-indicating that even though the time of case inclusion was extended, their absolute values did not fluctuate much. Thus, we do not consider "inclusion time" a factor affecting the data we presented. Nonetheless, more case numbers included in our Results analysis did lead to concordant statistical analysis: the trending of the serum creatinine recovering curves kept the same, and the p value become even smaller (<0.001); the DGF rate become significantly different (0.019); and the SGF rate become statistically different (0.047).
Although Moers et al. 10, 20 demonstrated graft survival benefit in the PMP kidneys, which had fewer DGF cases for 1 year and 3 year follow-up from a prospective randomized study, the long-term relationship between DGF and patient/graft survival remain controversial in the literature. 9, 16, [20] [21] [22] However, we did not observe such effect in this study. This could be because of several possibilities: small case numbers (altogether 19 cases of DGF among 105 recipients), short observation time (16-32 months follow-up), and the nature of retrospective study (no control of immunosuppression and other factors) are among the few which could explain why we did not see any differences in graft survival.
Some reports documented cost-effectiveness of pumped kidneys 4, 13, 23 ; however, our inpatient cost analysis did not show a significant difference between these two cohorts. One possibility is that cost-inflation of kidney transplantation over years made our comparisons not totally fair; and the other possibility is that there were two cases of posttransplant surgical complications in the pumped group (one toxic ischemic colitis and one incarcerated wound hernia; both unrelated to the use of pumping the kidneys), which falsely made the cost of the pumped group higher. Furthermore, many patients with DGF were discharged once surgically stable and were dialyzed in the outpatient setting by their community nephrologists, in which our records could not collect their all posttransplant outpatient costs due to the retrospective nature.
In conclusion, mechanical perfusion of the SCD kidneys in a geographically remote transplant center tended to be better than those preserved in static cold storage (fewer DGF, fewer SGF incidences; and much faster recovery of allograft); but except the recovery curve of serum creatinine, the other parameters failed to reach statistical significance in the post hoc examination of the contemporary groups when only limited case numbers in the control arm of the same follow-up period were included. A well-designed adequately powered prospective randomized study using paired kidneys from the same SCD should be able to provide more scientific evidence of a higher level to re-examine these positive findings of PMP of SCD kidneys in a geographically remote transplant center.
